Blog — Insights & Updates

PharmacovigilanceMarch 27, 2026 6 min

Scaling Pharmacovigilance Across Europe: Managing Local Requirements Without Losing Control

Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.

Read article

PharmacovigilanceMar 25, 2026 5 min

AI in Pharmacovigilance: Efficiency Tool or Strategic Game-Changer?

AI is transforming pharmacovigilance processes from case processing and literature monitoring to signal detection. Discover how AI and NLP can enhance efficiency, compliance, and regulatory intelligence.

Regulatory AffairsMar 25, 2026 4 min

From R&D to Market: Why the Product Lifecycle Is the Strategic Framework for MedTech

Successful MedTech companies treat product development as a lifecycle strategy. Learn why regulatory planning, IP strategy and development must evolve together.

Regulatory AffairsMar 24, 2026 3 min

SaMD Under EU MDR: What Software Developers Need to Know

Developing Software as a Medical Device under EU MDR requires clear intended use, risk classification under Rule 11, and compliance with IEC 62304. Learn what SaMD developers need to know.

Regulatory AffairsMar 23, 2026 4 min

IP Strategy for MedTech Startups: What Early-Stage Companies Often Miss

IP strategy should start early in MedTech development. Discover how patent strategy, regulatory classification, and product development influence IP protection for emerging MedTech companies.

Regulatory AffairsMar 22, 2026 5 min

EU MDR Compliance for MedTech Startups: What It Really Takes

EU MDR compliance can be challenging for emerging MedTech companies. Learn what MDR actually requires, from qualification and QMS to technical documentation and post-market obligations.

Regulatory AffairsMar 21, 2026 4 min

3 Things MedTech Startups Get Wrong About IP & Regulatory Strategy

Many MedTech startups treat IP and regulatory strategy as separate disciplines. Discover the three most common mistakes and how aligning both early strengthens market access and product value.

Regulatory AffairsMar 4, 2026 4 min

Scientific Advice for Startups: Turning the Right Questions into Regulatory Clarity

Scientific Advice is one of the few moments in early development where a biotech can test its assumptions with regulators. Learn how to structure questions, integrate CMC and clinical strategy, and leverage EMA SME support for maximum impact.

Qualification & ValidationMar 4, 2026 4 min

People as a Critical Risk Factor in Annex 1: Personnel Gowning, Training and Aseptic Behaviour

Annex 1 places strong emphasis on personnel behaviour in sterile manufacturing. Learn how gowning, training, and aseptic discipline influence contamination control.

Regulatory AffairsMar 4, 2026 4 min

Pre-Submission Optimization for EU/UK: How US Biotechs Can Adapt FDA Packages Efficiently

For US biotechs expanding into the EU and UK, successful submission conversion requires early planning, clear ownership, and a structured approach. Learn how to build a reuse map, manage parallel conversion tracks, and avoid late-stage rework.

Qualification & ValidationFeb 25, 2026 3 min

Annex 15 Revision: What API Manufacturers Must Prepare for Now

The Annex 15 revision will make qualification and validation mandatory for API manufacturers. Learn how to prepare lifecycle validation and inspection readiness.

Regulatory AffairsFeb 18, 2026 4 min

Planning EU Expansion: What US Biotechs Must Get Right From Day One

Planning EU and UK expansion as a US biotech? Learn which regulatory, clinical and operational decisions matter from day one.

Lab ServicesFeb 18, 2026 3 min

Residual Solvent Testing in Pharmaceuticals: From Process to Patient

Residual solvent testing is essential to patient safety and regulatory compliance. Learn how GC-FID and GC-MS support ICH Q3C compliance in pharmaceutical manufacturing.